Document Detail


Comparison of Biolimus A9-Eluting (Nobori) and Everolimus-Eluting (Promus Element) Stents in Patients With De Novo Native Long Coronary Artery Lesions: A Randomized Long Drug-Eluting Stent V Trial.
MedLine Citation:
PMID:  24823426     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Procedural and clinical outcomes still remain unfavorable for patients with long coronary lesions who undergo percutaneous coronary intervention. The current study, therefore, evaluated 2 innovative drug-eluting stents for the management of long-lesion coronary artery disease.
METHODS AND RESULTS: This randomized, multicenter, prospective trial, called the Long Drug-Eluting Stent (LONG-DES) V trial, compared the biodegradable polymer-based biolimus A9-eluting stent (BES) and the durable polymer-based platinum chromium everolimus-eluting stent (PtCr-EES) in 500 patients with long (≥25 mm) coronary lesions. The primary end point of the trial was in-segment late luminal loss at the 9-month angiographic follow-up. The BES and PtCr-EES groups had similar baseline characteristics, with a slightly shorter lesion length in the BES group versus the PtCr-EES group (29.24±12.17 versus 32.27±13.84 mm; P=0.016). In-segment late luminal loss was comparable between the 2 groups at the 9-month angiographic follow-up (BES, 0.14±0.38 versus PtCr-EES, 0.11±0.37 mm; difference, 0.031; 95% confidence interval, -0.053 to 0.091; P=0.03 for a noninferiority margin of 0.11, P=0.45 for superiority), as was in-stent late luminal loss (0.20±0.41 versus 0.24±0.38 mm; P=0.29). The incidence of in-segment (6.1% versus 4.9%; P=0.63) and in-stent (3.7% versus 4.9%; P=0.59) binary restenosis was also similar between the groups. There was no significant between-group difference in the rate of composite outcome of death, myocardial infarction, and target vessel revascularization (41, 16.7% in BES versus 42, 16.5% in PtCr-EES; P=0.94).
CONCLUSIONS: BES and PtCr-EES implantation showed analogous angiographic and clinical outcomes for patients with de novo long coronary lesions.
CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01186120.
Authors:
Jong-Young Lee; Duk-Woo Park; Young-Hak Kim; Jung-Min Ahn; Won-Jang Kim; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Sung-Cheol Yun; Tae-Hyun Yang; Bong-Ki Lee; Nae-Hee Lee; Joo-Young Yang; Won-Yong Shin; Hun Sik Park; Kee-Sik Kim; Seung Ho Hur; Sung Yun Lee; Jong-Seon Park; Yun Seok Choi; Seung Uk Lee; Sung-Ho Her; Seung-Jung Park
Related Documents :
23021916 - Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal...
11834936 - Accuracy of low load exercise-induced t wave normalization in predicting the presence o...
134636 - Left atrial size in patients with atrial fibrillation: an echocardiographic study.
19868826 - Electrocardiographic evidence of myocardial involvement in rheumatic fever.
21831866 - Absorbed dose assessment of cardiac and other tissues around the cardiovascular system ...
11179056 - Vascular beta-adrenergic receptor system is dysfunctional after myocardial infarction.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-5-13
Journal Detail:
Title:  Circulation. Cardiovascular interventions     Volume:  -     ISSN:  1941-7632     ISO Abbreviation:  Circ Cardiovasc Interv     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-5-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101499602     Medline TA:  Circ Cardiovasc Interv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2014 American Heart Association, Inc.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Atypical cutaneous features in adult onset Still's disease.
Next Document:  New National Diabetes Footcare Audit of England and Wales.